True North buys 25% stake in pharma co Embio

Private equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will also help scale their contract development and manufacturing business. Embio specializes in complex APIs and synthetic biology.